Company / Current Assets
Dare Bioscience, Inc. Current Assets History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$27.1M
FY2025
5-year range
$17.5M / $77.3M
FY2021-FY2025
Trend
+46.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $18M to $27M over the past 2 years.
Based on SEC 10-K filings.
$27M in FY2025 with a 10-year CAGR of -10.0%.
Improved from $18M to $27M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -14.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -10.0%
Key checks
Key Insights
- 3-year CAGR of -14.3%, indicating a declining trend.
- In FY2025, current assets increased 46.7% year-over-year.
- Peak current assets was recorded in FY2016.
- Lowest current assets in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.1M | +46.7% |
| FY2024 | $18.4M | +5.2% |
| FY2023 | $17.5M | -59.2% |
| FY2022 | $43.0M | -44.3% |
| FY2016 | $77.3M | +0.0% |
| FY2015 | $77.3M | +46.3% |
| FY2014 | $52.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026